Achieve Life Sciences (NasdaqCM:ACHV) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Speaker8Greetings, and welcome to the Achieve Life Sciences fourth quarter and full year 2025 earnings conference call and webcast. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. You will be placed into question queue at any time by pressing star one on your telephone keypad. As a reminder, this conference is being recorded. If anyone should requi ...

Ocugen (NasdaqCM:OCGN) Update / briefing March 24, 2026 08:00 AM ET Company ParticipantsAngela Qian - VP of Global Capital MarketsArun Upadhyay - Chief Scientific OfficerElemer Piros - Managing Director of Healthcare Equity ResearchHuma Qamar - Chief Medical OfficerJay Chhablani - ProfessorLejla Vajzovic - Professor of Ophthalmology and CME Program DirectorShankar Musunuri - Chairman, CEO, and Co-founderSyed Shah - Vice Chair for Research and Digital MedicineTiffany Hamilton - Head of Corporate Communicatio ...

Sanara MedTech (NasdaqCM:SMTI) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsEduardo Rafael Martinez-Montes - Biotechnology Equity Research AssociateElizabeth Taylor - CFOSeth Yon - President and CEOOperatorWelcome to the Sanara MedTech fourth quarter and full year 2025 earnings conference call. Please note that this conference call is being recorded and a replay will be available on the investor relations page of the company's website shortly. The company issued its earnings release ...

Sanara MedTech (NasdaqCM:SMTI) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsElizabeth Taylor - CFOSeth Yon - President and CEOConference Call ParticipantsEduardo Rafael Martinez-Montes - Biotech Equity Research AnalystOperatorWelcome to the Sanara MedTech fourth quarter and full year 2025 earnings conference call. Please note that this conference call is being recorded and a replay will be available on the investor relations page of the company's website shortly. The company issued i ...

LightInTheBox (NYSE:LITB) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsJian He - CEOJoe Ramelli - Investor and Strategic ConsultantSerena Huang - Investor Relations ContactSuhai Ji - CFOOperatorHello, ladies and gentlemen. Thank you for standing by for LightInTheBox's Fourth Quarter and Full Year 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. After management's prepared remarks, there will be a question and answer session. Today's conference ca ...

Sisram Medical (SEHK:01696) H2 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsEyal Ben David - CEOJiahong Li - Co-CEO and CFOLior Dayan - ChairmanConference Call ParticipantsJin Xin Ding - AnalystJingheng He - AnalystNate Zhou - Equity Research AnalystNone - AnalystJingheng HeLadies and gentlemen, thank you for standing by, and welcome to Sisram Medical's 2025 annual results conference call. I am Jingheng He from CITIC Securities, and joining me today is our Chief Analyst, Yifan Du. Joini ...

Cadeler (NYSE:CDLR) H2 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsMikkel Gleerup - CEOPeter Brogaard Hansen - CFOConference Call ParticipantsAnders Rosenlund - AnalystDaniel Haugland - Equity Research AnalystJamie Franklin - Energy Research AnalystMartin Huseby Karlsen - Equity Research AnalystNone - AnalystOperatorGood morning, and welcome to Cadeler's third quarter 2025 earnings presentation. Presenting today are Mikkel Gleerup, Chief Executive Officer, and Peter Brogaard Hansen, Ch ...

NRx Pharmaceuticals (NasdaqCM:NRXP) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsJonathan Javitt - Founder, Chairman and CEOMichael Abrams - CFOPatrick R. Trucchio - Managing Director of Equity ResearchConference Call ParticipantsEdward Moon - AnalystThomas Shrader - Managing Director and Senior Biotechnology Equity Research AnalystOperatorMorning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Q4 2025 Results Conference Call. At this time, all lines are in listen-only ...

Sisram Medical (SEHK:01696) H2 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsEyal Ben David - CEOJiahong Li - Co-CEO and CFOLior Dayan - ChairmanConference Call ParticipantsJin Xin Ding - AnalystJingheng He - AnalystNate Zhou - Equity Research AnalystNone - AnalystJingheng HeLadies and gentlemen, thank you for standing by, and welcome to Sisram Medical's 2025 annual results conference call. I am Jingheng He from CITIC Securities, and joining me today is our Chief Analyst, Yifan Du. Joini ...

NRx Pharmaceuticals (NasdaqCM:NRXP) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsJonathan Javitt - Founder, Chairman and CEOMichael Abrams - CFOPatrick R. Trucchio - Managing Director of Equity ResearchConference Call ParticipantsEdward Moon - AnalystThomas Shrader - Managing Director and Senior Biotechnology Equity Research AnalystOperatorMorning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Q4 2025 results conference call. At this time, all lines are in listen-only ...